Women were less than half of the people tested for almost all of these common medicines.

NCT00739674

SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)

See it on ClinicalTrials.gov ↗

863 people

447 womenmiddle line = equal numbers416 men
Phase
PHASE3
Paid for by
Organon and Co
Finished
2010-01-01
Health conditions
Hypertension
Who could join
Anyone
Ages
18 Years – no maximum
Average age
mean 55.38 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 89.6% · Asian 6.7% · Other 1.9% · Black / African American 1.5% · Hispanic / Latina 0.3%

Women left out

  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    “Patient With Anuria Or Confirmed Clinically Significant Renal Or Hepatic Dysfunction (Taken From Current/Past Medical Records) And/Or Electrolyte Imbalance Laboratory Test Within The Last 3 Months Prior To Visit 1: Serum Creatinine \> 130 Ì…”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “…Aetiology (E.G., Uncorrected Renal Artery Stenosis, Malignant Hypertension, Hypertensive Encephalopathy. Patient With Symptomatic Heart Failure (Classes 3 And 4). Patient With A Prior Myocardial Infarction Or Stroke Within The Last 6 Months”
  • No cancer

    Women with current or past cancer were turned away.

    “…condary Hypertension Of Any Aetiology (E.G., Uncorrected Renal Artery Stenosis, Malignant Hypertension, Hypertensive Encephalopathy. Patient With Symptomatic Heart Failure (Classes 3 And 4). Patient With A Prior Myocardial Infarction Or Str…”

Study titles and rules are shown in their original English.